Log in

NASDAQ:KIDSOrthopediatrics Stock Price, Forecast & News

$36.07
-0.86 (-2.33 %)
(As of 04/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$34.69
Now: $36.07
$37.93
50-Day Range
$33.64
MA: $42.59
$49.04
52-Week Range
$28.19
Now: $36.07
$51.48
Volume78,125 shs
Average Volume194,840 shs
Market Capitalization$608.86 million
P/E RatioN/A
Dividend YieldN/A
Beta0.58
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard. It offers trauma and deformity procedures; scoliosis procedures for the treatment of spinal deformity; and sports medicine procedures. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2007 and is headquartered in Warsaw, Indiana.
Read More
Orthopediatrics logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 2.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.60 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:KIDS
CUSIPN/A
Phone574-268-6379

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$72.55 million
Book Value$8.51 per share

Profitability

Net Income$-13,730,000.00

Miscellaneous

Employees80
Market Cap$608.86 million
Next Earnings Date5/13/2020 (Estimated)
OptionableNot Optionable

Receive KIDS News and Ratings via Email

Sign-up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter.


Orthopediatrics (NASDAQ:KIDS) Frequently Asked Questions

How has Orthopediatrics' stock been impacted by COVID-19 (Coronavirus)?

Orthopediatrics' stock was trading at $39.75 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, KIDS shares have decreased by 9.3% and is now trading at $36.07. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Orthopediatrics?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthopediatrics in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Orthopediatrics.

When is Orthopediatrics' next earnings date?

Orthopediatrics is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for Orthopediatrics.

How were Orthopediatrics' earnings last quarter?

Orthopediatrics Corp (NASDAQ:KIDS) announced its earnings results on Wednesday, March, 4th. The company reported ($0.36) earnings per share for the quarter, missing the consensus estimate of ($0.25) by $0.11. The firm earned $18.95 million during the quarter, compared to analysts' expectations of $18.26 million. Orthopediatrics had a negative net margin of 18.93% and a negative return on equity of 12.15%. View Orthopediatrics' earnings history.

What guidance has Orthopediatrics issued on next quarter's earnings?

Orthopediatrics updated its FY 2020 After-Hours earnings guidance on Wednesday, March, 4th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $88.513-89.964 million, compared to the consensus revenue estimate of $88.38 million.

What price target have analysts set for KIDS?

5 brokerages have issued 1 year price targets for Orthopediatrics' shares. Their forecasts range from $46.00 to $54.00. On average, they anticipate Orthopediatrics' share price to reach $49.60 in the next year. This suggests a possible upside of 37.5% from the stock's current price. View analysts' price targets for Orthopediatrics.

Has Orthopediatrics been receiving favorable news coverage?

News coverage about KIDS stock has been trending very negative this week, according to InfoTrie. The research firm scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Orthopediatrics earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutOrthopediatrics.

Are investors shorting Orthopediatrics?

Orthopediatrics saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 1,517,000 shares, an increase of 17.6% from the February 27th total of 1,290,000 shares. Based on an average trading volume of 164,000 shares, the short-interest ratio is currently 9.3 days. Approximately 19.7% of the company's stock are sold short. View Orthopediatrics' Current Options Chain.

Who are some of Orthopediatrics' key competitors?

What other stocks do shareholders of Orthopediatrics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthopediatrics investors own include AbbVie (ABBV), Gilead Sciences (GILD), Intel (INTC), Enterprise Products Partners (EPD), Freeport-McMoRan (FCX), Akorn (AKRX), Advanced Micro Devices (AMD), Cisco Systems (CSCO), Primo Water (PRMW) and Boeing (BA).

Who are Orthopediatrics' key executives?

Orthopediatrics' management team includes the following people:
  • Mr. Mark C. Throdahl, Pres, CEO & Director (Age 68)
  • Mr. Fred L. Hite, CFO & Director (Age 51)
  • Mr. Daniel J. Gerritzen, VP of Legal & HR, Gen. Counsel and Sec. (Age 49)
  • Mr. David R. Bailey, Exec. VP (Age 40)
  • Mr. Gregory A. Odle, Exec. VP of Commercialization (Age 49)

When did Orthopediatrics IPO?

(KIDS) raised $52 million in an IPO on Thursday, October 12th 2017. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Piper and Jaffray Stifel served as the underwriters for the IPO and William Blair and BTIG were co-managers.

What is Orthopediatrics' stock symbol?

Orthopediatrics trades on the NASDAQ under the ticker symbol "KIDS."

How do I buy shares of Orthopediatrics?

Shares of KIDS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Orthopediatrics' stock price today?

One share of KIDS stock can currently be purchased for approximately $36.07.

How big of a company is Orthopediatrics?

Orthopediatrics has a market capitalization of $608.86 million and generates $72.55 million in revenue each year. The company earns $-13,730,000.00 in net income (profit) each year or ($0.87) on an earnings per share basis. Orthopediatrics employs 80 workers across the globe. View additional information about Orthopediatrics.

What is Orthopediatrics' official website?

The official website for Orthopediatrics is http://www.orthopediatrics.com/.

How can I contact Orthopediatrics?

Orthopediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The company can be reached via phone at 574-268-6379 or via email at [email protected]

This page was last updated on 4/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel